Facebook
facebook

The Established Safety of AFSTYLA

AFSTYLA safety was evaluated in one of the largest FVIII clinical trial programs with 258 participants

ZERO INHIBITORS

14 of 258 participants reported a side effect

One person withdrew due to a side effect (allergic reaction).

Most common side effects

SIDE EFFECTS
You are now leaving the current website.

Do you want to continue?

No Yes